Zhao, S., Meng, M., Cheng, R., Zhang, M., Liu, C., Meng, Q., . . . Su, Y. Anlotinib inhibits c-MET and ITGA2 in the treatment of anaplastic thyroid carcinoma. BMC.
Chicago Style (17th ed.) CitationZhao, Shunshun, et al. Anlotinib Inhibits C-MET and ITGA2 in the Treatment of Anaplastic Thyroid Carcinoma. BMC.
MLA (9th ed.) CitationZhao, Shunshun, et al. Anlotinib Inhibits C-MET and ITGA2 in the Treatment of Anaplastic Thyroid Carcinoma. BMC.
Warning: These citations may not always be 100% accurate.